American Healthcare REIT (NYSE:AHR) Posts Earnings Results, Beats Estimates By $0.02 EPS

American Healthcare REIT (NYSE:AHR) released its quarterly earnings data on Thursday. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.02, Zacks reports. American Healthcare REIT had a return on equity of 3.63% and a net margin of 4.84%. The business had revenue of $742.15 million for the quarter, compared to the consensus estimate of $703.51 million. During the same quarter in the prior year, the business posted $0.44 EPS. The business’s revenue for the quarter was up 29.5% on a year-over-year basis.

American Healthcare REIT Stock Up 1.8%

Shares of NYSE AHR opened at $58.97 on Tuesday. The stock has a market cap of $12.86 billion, a PE ratio of 29.06, a price-to-earnings-growth ratio of 1.38 and a beta of 0.78. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.24. American Healthcare REIT has a 52-week low of $44.81 and a 52-week high of $59.22. The business has a 50-day moving average price of $53.15 and a 200 day moving average price of $51.70.

American Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Wednesday, September 30th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend was Wednesday, September 30th. American Healthcare REIT’s payout ratio is presently 204.08%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on AHR shares. Scotiabank upped their price target on American Healthcare REIT from $56.00 to $62.00 and gave the company an “outperform” rating in a report on Wednesday, September 2nd. Barclays cut their price objective on shares of American Healthcare REIT from $66.00 to $60.00 and set an “overweight” rating on the stock in a report on Tuesday, October 13th. Citigroup restated a “market outperform” rating on shares of American Healthcare REIT in a research report on Monday, September 14th. Royal Bank Of Canada upped their target price on shares of American Healthcare REIT from $56.00 to $61.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Finally, Weiss Ratings downgraded shares of American Healthcare REIT from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, October 6th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $62.00.

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, EVP Mark Foster sold 2,000 shares of American Healthcare REIT stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $55.39, for a total transaction of $110,780.00. Following the transaction, the executive vice president owned 51,617 shares of the company’s stock, valued at $2,859,065.63. The trade was a 3.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.75% of the stock is owned by corporate insiders.

About American Healthcare REIT

American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses.

The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care.

American Healthcare REIT began trading on the New York Stock Exchange in 2024.